Ceftazidime in pharma franchise in Punjab

Ceftazidime in PCD pharma franchise in Raipur

Ceftazidime in top pharma company in Tiruchirappalli

Ceftazidime in pcd pharma supplier in Belagavi

Ceftazidime in phama franchise company in India
Ceftazidime in phama distributor in Nellore

Home/Products /ceftazidime-250mg-injection

Dimezeft 250 Injection

Composition : Ceftazidime (250mg)

Dosage Form : Injection

Packaging Type : Vial + Water

Packaging : 250mg

Price : ₹82/-

Dimezeft 250 Injection contains Ceftazidime, a third-generation cephalosporin antibiotic known for its broad-spectrum activity against gram-negative and gram-positive bacteria. It works by inhibiting bacterial cell wall synthesis, leading to the elimination of the infection. This formulation is particularly effective for treating severe infections caused by susceptible microorganisms, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, septicemia, and abdominal infections.

Ceftazidime is also highly effective against Pseudomonas aeruginosa, making it an essential choice for hospital-acquired infections. Dimezeft 250 Injection is administered intravenously or intramuscularly, depending on the severity and type of infection. Its rapid action ensures prompt relief from bacterial infections while minimizing the risk of complications.

Read More

About the Product

Dimezeft 250 Injection contains Ceftazidime, a third-generation cephalosporin antibiotic known for its broad-spectrum activity against gram-negative and gram-positive bacteria. It works by inhibiting bacterial cell wall synthesis, leading to the elimination of the infection. This formulation is particularly effective for treating severe infections caused by susceptible microorganisms, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, septicemia, and abdominal infections.

Ceftazidime is also highly effective against Pseudomonas aeruginosa, making it an essential choice for hospital-acquired infections. Dimezeft 250 Injection is administered intravenously or intramuscularly, depending on the severity and type of infection. Its rapid action ensures prompt relief from bacterial infections while minimizing the risk of complications.

Common side effects may include injection site reactions, nausea, vomiting, diarrhea, and rash.

Used for treating severe bacterial infections, including respiratory, urinary, skin infections, and septicemia.

Use only under medical supervision. Complete the full course of treatment to avoid antibiotic resistance.

Store at room temperature, below 25°C, away from light and moisture.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation